ACSM2B (Gene)

Organism:

Homo sapiens

Synonyms:ACSM2, ACSM2B, ENTREZ:348158, HGNC:30931, HXMA, HYST1046, MIM:614359, NM_001105069, NM_182617, NP_001098539, NP_872423, XM_005255304, XM_011545824, XM_017023205, XP_005255361, XP_011544126, XP_016878694, XR_001751899, acyl-CoA synthetase medium chain family member 2B

Omim:OMIM:614359

Id:ENSG00000066813

Hgnc:HGNC:30931

Entrez:348158

Ensembl:ENSG00000066813

Description:acyl-CoA synthetase medium chain family member 2B

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View ACSM2B's neighborhood in the knowledge graph.

Submit

Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with ACSM2B.

CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using ACSM2B.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for ACSM2B.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with ACSM2B.

Results found

Linked to

	Label	Description
	GSE208350 H-7 Huh-7 JHH-7 0 v 8 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE242333 sorafenib 0 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE228430 FABP5 inhibition Huh-7 1 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE242333 0 V 2 SORAFENIB HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE225523 GSE225527 FOXO1 overexpression CAR 1 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE218773 ABL2 knockdown Hep-G2 2 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE199107 tryptophan 6 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE218773 ABL2 knockdown Hep-G2 3 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE150895 GSE150896 enzalutamide 0 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE109140 0 V 3 VALPROIC ACID HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS

GSE208350 H-7 Huh-7 JHH-7 0 v 8 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE242333 sorafenib 0 v 2 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE228430 FABP5 inhibition Huh-7 1 v 0 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE242333 0 V 2 SORAFENIB HUMAN DN

Gene Set (Entity type)

A Gene Set from LINCS

GSE225523 GSE225527 FOXO1 overexpression CAR 1 v 2 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE218773 ABL2 knockdown Hep-G2 2 v 1 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE199107 tryptophan 6 v 1 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE218773 ABL2 knockdown Hep-G2 3 v 0 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE150895 GSE150896 enzalutamide 0 v 1 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE109140 0 V 3 VALPROIC ACID HUMAN DN

Gene Set (Entity type)

A Gene Set from LINCS

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

CFDE Workbench

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.